11-Hydroxyprogesterone (11-OHP)
11-Beta-hydroxyprogesterone
-99517.gif)
Very large doses of progesterone cause exacerbation of diabetes in the partially depancreatized, forcefed rat. The diabetogenic potency of 11-ketoprogesterone is greater than that of progesterone. The diabetogenicity of 11β-hydroxyprogesterone is as great or greater than that of 11-ketoprogesterone and each of these compounds is much more potent than llα-hydroxyprogesterone. 11-ketoprogesterone is diabetogenic and that llα-hydroxyprogesterone is relatively inactive was in unpublished experiments. Male rats of the Sprague-Dawley strain were maintained on Archer Dog Pellets until the metabolic studies were begun. The animals were partially depancreatized at a weight of 275 to 280 gms. After diabetes was established all of the rats were placed in metabolism cages and force-fed a medium carbohydrate diet by stomach tube each morning.
Organism species: Pan-species (General)
- Conjugated small molecules CPK517Ge11 BSA Conjugated 11-Hydroxyprogesterone (11-OHP) In Stock
- Conjugated small molecules CPK517Ge21 OVA Conjugated 11-Hydroxyprogesterone (11-OHP) In Stock
- Polyclonal antibody PAK517Ge01 Polyclonal Antibody to 11-Hydroxyprogesterone (11-OHP) In Stock
- Monoclonal antibody MAK517Ge21 Monoclonal Antibody to 11-Hydroxyprogesterone (11-OHP) In Stock
- Monoclonal antibody MAK517Ge22 Monoclonal Antibody to 11-Hydroxyprogesterone (11-OHP) In Stock
- Monoclonal antibody MAK517Ge23 Monoclonal Antibody to 11-Hydroxyprogesterone (11-OHP) In Stock
- Monoclonal antibody MAK517Ge24 Monoclonal Antibody to 11-Hydroxyprogesterone (11-OHP) In Stock
- Customized Service n/a CLIA Kit for 11-Hydroxyprogesterone (11-OHP) CLIA Kit Customized Service Offer
- Customized Service n/a ELISA Kit for 11-Hydroxyprogesterone (11-OHP) ELISA Kit Customized Service Offer